Biotech
Champions Oncology to Announce Second Quarter Financial Results on Monday, December 13, 2021
HACKENSACK, NJ / ACCESSWIRE / December 6, 2021 / Champions Oncology, Inc. (NASDAQ:CSBR), leaders in transformative technology solutions utilized in oncology drug discovery and development will report its financial and operational results for the second more...
Biotech
Citius Pharmaceuticals Completes Enrollment in the Pivotal Phase 3 Study of its Cancer Immunotherapy I/ONTAK for the Treatment of Cutaneous T-Cell Lymphoma
Citius Pharmaceuticals Completes Enrollment in the Pivotal Phase 3 Study of its Cancer Immunotherapy I/ONTAK for the Treatment of Cutaneous T-Cell Lymphoma Topline study results expected in the first half of 2022 Biologics License Application more...
Biotech
Atossa Therapeutics Completes Pre-IND Meeting with U.S. Food & Drug Administration
Input Received on Pathway for Proprietary Z-Endoxifen to Treat Breast Cancer in Neoadjuvant Setting SEATTLE, Dec. 06, 2021 (GLOBE NEWSWIRE) — Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company seeking to develop innovative proprietary more...
Biotech
Oncocyte Corporation Hosting Business Update Call
Tuesday, December 14th @ 2:30pmET IRVINE, Calif., Dec. 06, 2021 (GLOBE NEWSWIRE) — Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics and monitoring company with the mission to improve patient outcomes by providing clear insights that more...
Biotech
AGTC Appoints Biopharmaceutical Industry Leader James Robinson to its Board of Directors
Robinson’s expertise in development and commercialization adds to the clinical and commercial experience of newly appointed management team GAINESVILLE, Fla. and CAMBRIDGE, Mass., Dec. 06, 2021 (GLOBE NEWSWIRE) — Applied Genetic Technologies Corporation (Nasdaq: AGTC), a more...
Biotech
Curis Appoints John A. Hohneker, M.D. To Board Of Directors
Curis Appoints John A. Hohneker, M.D. To Board Of Directors PR Newswire LEXINGTON, Mass. , Dec. 6, 2021 /PRNewswire/ — Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for more...
Biotech
Bellicum Announces Positive Interim Data from Phase 1/2 GoCAR-T® Studies, Secures $35 Million Private Placement Equity Financing Priced at Market
– Confirmed partial response observed in one patient in first cohort of metastatic castration-resistant prostate cancer (mCRPC) patients treated with BPX-601 – – Favorable safety profile observed in initial dose cohort of BPX-603 in HER2+ more...
Biotech
ASLAN Pharmaceuticals and IQVIA Biotech Enter Into Strategic Collaboration
MENLO PARK, Calif. and SINGAPORE, Dec. 06, 2021 (GLOBE NEWSWIRE) — ASLAN Pharmaceuticals (Nasdaq: ASLN), a clinical-stage, immunology-focused biopharmaceutical company developing innovative treatments to transform the lives of patients, today announced the appointment of IQVIA more...
Biotech
Aeglea BioTherapeutics Announces Achievement of Primary Endpoint in Phase 3 Study of Pegzilarginase in Patients with Arginase 1 Deficiency
Aeglea BioTherapeutics Announces Achievement of Primary Endpoint in Phase 3 Study of Pegzilarginase in Patients with Arginase 1 Deficiency 80% plasma arginine reduction (primary endpoint; p < 0.0001) accompanied by a positive trend in GMFM-E, more...
Biotech
Matinas BioPharma Appoints Thomas Hoover, M.B.A. as Chief Business Officer
BEDMINSTER, N.J., Dec. 06, 2021 (GLOBE NEWSWIRE) — Matinas BioPharma Holdings, Inc. (NYSE AMER: MTNB), a clinical-stage biopharmaceutical company focused on improving the intracellular delivery of critical therapeutics through its paradigm-changing lipid nanocrystal (LNC) platform delivery more...